Time to Onset of Response of AbobotulinumtoxinA in the Treatment of Glabellar Lines: A Subset Analysis of Phase 3 Clinical Trials of a New Botulinum Toxin Type A

Author： SCHLESSINGER JOEL   MONHEIT GARY   KANE MICHAEL A.C.   MENDELSOHN NAOMI  

Publisher： Elsevier

ISSN： 1076-0512

Source： Dermatologic Surgery, Vol.37, Iss.10, 2011-10, pp. : 1434-1442

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

AbobotulinumtoxinA for Reduction of Glabellar Lines in Patients with Skin of Color: Post Hoc Analysis of Pooled Clinical Trial Data

By Taylor Susan C.   Callender Valerie D.   Albright Craig D.   Coleman Jeffrey   Axford-Gatley Robert A.   Lin Xiaoming  

Dermatologic Surgery, Vol. 38, Iss. 11, 2012-11 ,pp. : 1804-1811

Elsevier

Access to resources Recommend Favorite

Botulinum A Toxin for Glabellar Wrinkles

By HANKINS CHRISTOPHER L.   STRIMLING ROBERT   ROGERS GARY S.  

Dermatologic Surgery, Vol. 24, Iss. 11, 1998-11 ,pp. : 1181-1183

Elsevier

Access to resources Recommend Favorite

Glabellar Contraction Patterns: A Tool to Optimize Botulinum Toxin Treatment

By Almeida Ada R. Trindade   Costa Marques Elisa R. M.   Banegas Raul   Kadunc Bogdana V.  

Dermatologic Surgery, Vol. 38, Iss. 9, 2012-09 ,pp. : 1506-1515

Elsevier

Access to resources Recommend Favorite

Botulinum toxin type A for the treatment of migraine

By Aurora Sheena  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 8, 2006-06 ,pp. : 1085-1095

Informa Healthcare

Access to resources Recommend Favorite

Botulinum toxin type B: a new injectable treatment for cervical dystonia

By Brashear Allison  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 12, 2001-12 ,pp. : 2191-2199

Informa Healthcare

Access to resources Recommend Favorite